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Low incidence of Pneumocystis carinii pneumonia in HIV patients 
receiving 300 mg pentamidine aerosol every 2 weeks 
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Investigator 
Summary. The optimal dosage of pentamidine for 
prophylaxis of Pneumocystis carinii pneumonia 
(PcP) is unknown. We assessed the effects of 
300 mg pentamidine inhaled every 2 weeks. Salbu-
tamol was added for prevention of bronchocon-
striction. A total of 128 consecutive HIV patients 
were enrolled, 21 of whom were excluded within 
8 weeks; the remaining 107 patients, 66 on primary 
and 41 on secondary prophylaxis, were treated for 
39 weeks (median; range 8-133). Two patients de­
veloped PcP. Side effects occurred in only 14 of 
5082 inhalations. Three patients developed hypo­
glycemia after inhalations. Blood glucose levels de­
termined in 34 patients before and after inhalation 
revealed a decline from 89 + 23 mg/dl to 79 ± 
23 mg/dl (P< 0.005). A randomized prospective 
trial is necessary to evaluate the efficacy of 300 mg 
pentamidine inhaled every 4 or 2 weeks. 
Key words: HIV - Pneumocystis carinii - Prophy­
laxis - Pentamidine 
The incidence of Pneumocystis carinii pneumonia 
(PcP) has significantly declined since pentamidine 
aerosol became available for prophylaxis in 1988. 
Nevertheless, up to now both the optimal dosage 
of pentamidine and the interval between the inha­
lations is unknown. In a randomized dose escalat­
ing study (30 mg inhaled every 2 weeks, 150 mg 
every 2 weeks, 300 mg every 4 weeks) the highest 
dose was related to the highest efficacy [4]. We 
report on the effects of 300 mg pentamidine in­
haled every 2 weeks for primary and secondary 
prophylaxis of PcP, a dose twice as high as that 
used by Leoung and colleages [7]. 
Patients and methods 
HIV-infected patients with AIDS and patients with 
a CD4 cell count below 250/μ1 were eligible. Pa-
Ahbreviation: PcP = Pneumocystis carinii pneumonia 
tients on secondary prophylaxis started pentami­
dine inhalation at the end of a 3-week course of 
high-dose intravenous cotrimoxazole. A total of 
128 consecutive patients were enrolled (118 men 
and 10 women). Pentamidine 300 mg isethionate 
was inhaled every 2 weeks by a Respigard I I nebu­
lizer system (Marquest, Englewood, Colorado) 
linked to an jet-air stream compressor (Salvia, 
Hamburg, FRG) with an air flow of 7 1/min. Pen­
tamidine was dissolved in 6 ml aqua ad injectabilia. 
Salbutamol 1 ml (5 mg) was added for prophylaxis 
of bronchospasm. The patients inhaled pentami­
dine in the outpatient department, in a sitting posi­
tion wearing a nasal clamp. They were questioned 
about side effects after each inhalation. To deter­
mine the effects of pentamidine aerosol on blood 
glucose levels, venous blood specimen were drawn 
immediately before and after the inhalation. An 
inhalation lasted about 30 min. 
Results 
Within 8 weeks 21 patients were withdrawn: 19 
because of non-compliance, and 2 patients died. 
One died 2 days after enrollment; autopsy revealed 
PcP, pulmonary aspergillosis, and disseminated cy­
tomegalovirus infection. The second patient died 
of pulmonary aspergillosis after 7 weeks. No Pneu-
mocystis carinii was detected at autopsy. Thus 107 
patients were treated for at least 8 weeks and con­
sidered eligible for determining the efficacy of pen­
tamidine inhalation. Their mean CD4 cell count 
was 105±114/μ1. Of these, 66 (62%) received pri­
mary prophylaxis and 41 (38%) secondary prophy­
laxis. Their characteristics are shown in Table 1. 
Two patients developed PcP, confirmed by 
bronchoalveolar lavage. One was a 38-year-old 
man on secondary prophylaxis. He had suffered 
from a first episode of PcP 6 weeks prior to enroll­
ment. He had been treated with cotrimoxazole in­
travenously for 3 weeks. On the last day of Cotri­
moxazol treatment prophylaxis was initiated. After 
12 weeks on pentamidine inhalation PcP was diag-
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Table 1. Patient's characteristics at study entry (only patients 
on prophylaxis for at least 8 weeks are included) 
Characteristic Primary 
prophylaxis 
(,7 = 66) 
Secondary 
prophylaxis 
(w = 41) 
Age (years) 
Mean 40 38 
Range 23-74 24-59 
C D 4 count ( x l 0 9 / l ) 
Mean 125 81 
Range 8-739 a 0 - 6 0 1 a 
Weeks on prophylaxis 
Mean 44 54 
Range 8-133 12-126 
Medication taken 
Zidovudine 37 (56%) 16(39%) 
Acyclovir 5 ( 8%) 2 (5%) 
Ganciclovir 1 (2%) 2 (5%) 
Pyrimethamine 5 ( 8 % ) 3 (7%) 
Clindamycin 5 (8%) 3 (7%) 
Ketoconazole 11 (17%) 14(34%) 
HIV-related conditions (except PcP) 
Candida esophagitis 10(15%) 4 ( 1 1 % ) 
C M V 2 (3%) 2 (5%) 
Toxoplasmosis 5 (8%) 3 (7%) 
M A I infection 4 (6%) 3 (7%) 
Kaposi's sarcoma 9 ( 1 4 % ) 4 ( 1 1 % ) 
Lymphoma 2 (3%) 0 (0%) 
Other 9 ( 1 4 % ) 8 (21%) 
C M V , Cytomegalovirus infection; M A I , Mycobacterium avium/ 
intracellulare complex 
a Patients wi th A I D S according to the criteria o f the Centers 
for Disease Cont ro l 
nosed, to which the patient succumbed 1 week 
later. The second was a 74-year-old man on prima­
ry prophylaxis. PcP developed after 39 weeks, be­
ing the first manifestation of full-blown AIDS. The 
patient was successfully treated with Cotrimoxa­
zol^. Of the 107 patients 54 had to be taken off 
the protocol, 25 on primary and 29 on secondary 
prophylaxis. Of these, 46 died; there was no clini­
cal suspicion of PcP in any of them. Eight patients 
were lost to follow-up. Autopsy was performed in 
19 of 46 patients. Pneumocystis carinii was found 
in the lungs of one patient who had been on sec­
ondary prophylaxis for 1 year. Pentamidine inhala­
tion had been introduced immediately after the 
first episode of PcP. This patient died of a cerebral 
hemorrhage. In the remaining 18 patients no Pneu-
mocystis carinii was detected in any tissue. 
Fourteen of the 128 patients reported side ef­
fects. Five complained of cough, three of dizziness, 
three of ravenous appetite, two of numbness of 
the face, and one each of nausea, dyspnea, and 
burning pain of the chest. One patient stopped in­
halation because of a bronchospasm despite salbu-
tamol. The other side effects were tolerable and 
occurred once in each patient. Thus, side effects 
occurred in 14 of 5082 inhalations (0.3%). The 
three patients with reported ravenous had blood 
glucose levels below 60 mg/dl. To elucidate the co­
incidence of hypoglycemia and inhalation of penta­
midine, we determined the blood glucose levels in 
34 consecutive fasting patients (Fig. 1). The mean 
blood glucose before inhalation was 89 ± 2 3 mg/dl 
and 79 ± 2 3 mg/dl after inhalation (P< 0.005; / 
test). In one patient blood glucose decreased from 
102 to 49 mg/dl. After inhalation of 6 ml normal 
saline solution there was no substantial change of 
the blood glucose levels in six patients who also 
received pentamidine inhalation. 
Discussion 
Until 1988 PcP was the most common opportunis­
tic disease and a major cause of death in HIV-
infected patients. It has been estimated that about 
75% of AIDS patients develop PcP at some time 
during their illness [5]. The incidence of PcP over 
12 months is about 18% in patients with a CD4 




Fig. 1. Blood glucose levels in 34 consecu­
tive patients before and after inhalation o f 
300 mg pentamidine. Mean blood glucose 
levels were 89 ± 2 3 mg/dl before and 79 + 
23 mg/dl after inhalat ion (P< 0.005). 
Three patients had identical blood glucose 
levels before and after inhala t ion; for 
these only one dot is shown. • , Blood 
glucose levels before inhalat ion; • . blood 
glucose levels after inhalat ion 
patients 
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Only two of 107 patients (2%) developed PcP 
over a mean observation period of 48 weeks while 
on prophylaxis with 300 mg pentamidine aerosol 
given every 2 weeks. In another patient Pneumocys-
tis carinii was detected in the lungs at autopsy with­
out clinical signs of pneumonia. Recently the re­
sults of prophylaxis with 300 mg pentamidine ad­
ministered every 4 weeks were reported [7]. Of 139 
patients 16 (12%) on primary or secondary pro­
phylaxis developed PcP over an observation period 
of 30 weeks (median). The mean CD4 cell count 
was 161/μ1. When patients received the same regi­
men for primary prophylaxis, 6 of 114 patients 
(5%) developed PcP over a mean observation peri­
od of 3 months [6]; the mean CD4 cell counts 
were 140/μ1. In contrast, only 7 of 120 patients 
(6%) who received 200 mg pentamidine aerosol 
every 2 weeks for primary or secondary prophylax­
is developed PcP over a mean observation period 
of 9 months [9]; the mean CD4 cell count was 
68/μ1. The low incidence of PcP after administra­
tion of 300 mg pentamidine every 2 weeks seems 
remarkable. Augmentation of the volume by ad­
ding 1 ml salbutamol and an improved distribution 
of the aerosole in the lungs compared with applica­
tion separately from the aerosole may in part ac­
count for these differences. In addition, study pop­
ulations and observation periods are not identical. 
A randomized trial is necessary to determine 
whether a lower incidence of PcP can be achieved 
by inhalation of 300 mg pentamidine every 2 
weeks. These results may be of particular interest 
concerning patients with a CD4 cell count below 
50/μ1, as these patients seem to have an increased 
risk of developing PcP [9]. 
Single administration of pentamidine aerosol 
results in high lung levels in rats, which do not 
decrease during the first 48 h after aerosolization 
[2]. In patients receiving daily pentamidine inhala­
tion for treatment of PcP drug levels were deter­
mined in bronchoalveolar lavage at different time 
points [1]. There was no significant difference be­
tween the pentamidine concentration after 1 and 
15 days of therapy, suggesting that there is no ac­
cumulation of pentamidine in the lungs. One 
month after completion of 2 weeks' therapy, the 
concentration of pentamidine in the bronchoalveo­
lar lavage was approximately 10% of that deter­
mined during treatment. These data suggest that 
2-weekly inhalation of pentamidine may result in 
higher drug levels in the lungs compared to 4-week-
ly administration, thereby reducing the incidence 
of PcP. Side effects occurred in 0.3% of inhala­
tions. Cough is reported in about 30% of pentami­
dine inhalations [6, 7]. The extremely low occur­
rence of cough in our study is probably related 
to the routine administration of salbutamol. No 
side effects related to salbutamol itself were no­
ticed. Hypoglycemia has been reported after intra­
venous administration of pentamidine [4]. Blood 
glucose levels were significantly reduced after inha­
lation of 300 mg pentamidine. Recently 25 patients 
were studied for effects of pentamidine inhalation 
on blood glucose levels [3]. They experienced a 
significant decrease in glucose levels and a simulta­
neous increase in serum insulin levels. To avoid 
this side effect patients should not be fasting when 
inhaling pentamidine. 
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